Supplementary Methods and References from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S4 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tomomi Matsuura et al.|Unknown|2024Cited by 0
Supplementary Fig.S8 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S12 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S9 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0